The goal of this clinical trial is to investigate the effects of core stabilization exercises applied in addition to the conventional exercise program on physical function, functional muscle strength, functional exercise capacity, postural control and fatigue in children with acute lymphoblastic leukemia receiving maintenance treatment. Participants will be divided into two groups; the first group will be given a conventional exercise program, while the second group will be given core stabilization exercises in addition to the conventional exercise program.
Acute Lymphoblastic Leukemia (ALL) is a malignancy resulting from the abnormal proliferation of lymphoid cells that can invade the bone marrow, blood, and extramedullary regions, and it is the most common malignancy in childhood. Specific chemotherapy-related problems are frequently observed in children with ALL. These include a reduction in cardiopulmonary fitness, balance, posture, proximal muscle strength, and flexibility, as well as postural control issues and functional mobility impairments, in addition to fatigue. The aim of this study is to investigate the effects of core stabilization exercises, applied in addition to a conventional exercise program, on physical function, functional muscle strength, functional exercise capacity, postural control, and fatigue in children with Acute Lymphoblastic Leukemia undergoing maintenance therapy. Participants will be divided into two groups: the first group will follow a conventional exercise program, while the second group will receive core stabilization exercises in addition to the conventional program. All participants will be randomly assigned to the groups using the software available at http://www.randomizer.org. The exercise sessions will be conducted three times a week for a total of 8 weeks, with 24 sessions in total. Demographic information will be recorded for participants who agree to take part in the study and meet the inclusion criteria. The scales and tests designed to assess the participants' physical function, functional muscle strength, functional exercise capacity, postural control, and fatigue will be administered both before and after the study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
34
Aerobic exercise and stretching exercises will be applied in the conventional exercise program. A 20-30 minute walking will be done as aerobic exercise. Stretching exercises will be done for major muscle groups in 3 sets and 10 repetitions.
In addition to the conventional exercise program, core stabilization exercises will be applied. During the exercises, participants will be trained on neutralizing the spine and working the transverse abdominis and multifidus muscles, correct postural control, and performing the exercises with diaphragmatic breathing.
Necmettin Erbakan University
Konya, Turkey (Türkiye)
RECRUITINGTimed Up and Go Test (TUG)
This test aims to evaluate the physical function.
Time frame: Before 8 weeks of treatment
Timed Up and Go Test (TUG)
This test aims to evaluate the physical function.
Time frame: After 8 weeks of treatment
Sit-up Test
This test aims to evaluate the functional muscle strength
Time frame: Before 8 weeks of treatment
Sit-up Test
This aims to evaluate the functional muscle strength.
Time frame: After 8 weeks of treatment
6-Minute Walk Test
This test aims to evaluate the functional exercise capacity.
Time frame: Before 8 weeks of treatment
6-Minute Walk Test
This test aims to evaluate the functional exercise capacity.
Time frame: After 8 weeks of treatment
Balance Error Scoring System
This test aims to evaluate the postural control.
Time frame: Before 8 weeks of treatment
Balance Error Scoring System
This test aims to evaluate the postural control.
Time frame: After 8 weeks of treatment
Pediatric Quality of Life Multidimensional Fatigue Scale
This scale aims to evaluate the fatigue in pediatric patients.
Time frame: Before 8 weeks of treatment
Pediatric Quality of Life Multidimensional Fatigue Scale
This scale aims to evaluate the fatigue in pediatric patients.
Time frame: After 8 weeks of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.